Project Grant R24OD038116

Award Date 8/1/25
Completion Date 7/31/29
Dollars Obligated $778K
Funding Federal Agency
Office of the Director
Federal Grant Program
93.351
Assistance Type
Project Grant
Place of Performance
Colorado, USA
Similar Awards
This federal Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) provides $779,657 to the University of Colorado-Denver to establish and expand community-accessible resources for site-directed transgenesis in zebrafish. The project aims to generate next-generation landing site strains for reporter and enhancer testing applications, as well as streamline mapping of established transgenes to identify additional safe-harbor sites...
This federal Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (ORIP) under CFDA 93.351 provides $490,145 to the University of Massachusetts to produce and validate monoclonal antibodies that can enhance rigor and reproducibility in research using vertebrate animal models. The goal is to develop antibodies that recognize proteins in diverse animal models like mice, Xenopus, and axolotl to facilitate biomedical research using these...
This Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) is providing $194,375 to the University of Wisconsin - Madison to develop advanced genome editing tools for the zebrafish model organism. The key products to be delivered include: Establishing a reliable method for generating conditional knockout alleles in zebrafish using a synthetic exon-mediated integration approach to insert LoxP sites. This will enable conditional...
This Project Grant award of $743,926 from the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) will develop a resource of rigorously validated, translatable zebrafish models of previously undiagnosed human genetic diseases. The project will analyze genetic variants obtained from patients with rare, undiagnosed diseases through collaboration with clinical research consortia, and then generate humanized zebrafish models using CRISPR/Cas9 technology....
This federal Project Grant award from the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) provides $607,682 to the Oklahoma Medical Research Foundation (OMRF) from July 2024 to June 2028. The project aims to develop scalable methods for rapid phenotyping and functional testing of genetic variants using zebrafish models. Specifically, the award will fund the creation of an 80-mutant knockout library and the optimization of CRISPR-based base editing...
This Project Grant award from the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) aims to develop efficient methods for introducing small genetic changes, known as single nucleotide polymorphisms (SNPs) and variants of uncertain significance (VUS), into the zebrafish genome. The $181,754 award to Iowa State University, effective from September 15, 2024 to August 31, 2026, will leverage the university's "GenEweld" gene editing technology to...
This $553,708 Project Grant award from the National Institute of Environmental Health Sciences (NIEHS), under the Environmental Health (CFDA 93.113) program, aims to advance the development of a community-led Zebrafish Toxicology Phenotype Atlas. The key products and services to be delivered include: Designing and deploying a standardized Toxicophenotype Data Model to improve data compatibility across zebrafish toxicology studies and domains. Creating a Toxicophenotype Annotation Toolkit to...
This Project Grant award, funded by the U.S. Department of Agriculture's (USDA) National Institute of Food and Agriculture under the Agriculture and Food Research Initiative (AFRI) program (CFDA 10.310), focuses on advancing knowledge and developing solutions to address disease and health management challenges in the growing U.S. aquaculture industry. The $649,995 award, spanning from September 1, 2024 to August 31, 2027, supports research to study the mechanisms of immune response and...
This $448,150 Project Grant awarded by the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) aims to develop a DNA-based toolbox for the rapid and precise modulation of cell membrane protein-protein interactions (PPIs). The goal is to establish a modular approach using antibodies and aptamers to enable targeted DNA barcoding of cell membrane proteins, particularly receptor tyrosine kinases. This will allow for the controlled stabilization of specific PPI pairs on living...
This federal Project Grant award in the amount of $271,495.00, provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), supports the development and evaluation of a time-of-flight (TOF) mass spectrometer system with matrix-assisted laser desorption/ionization (MALDI) for fast analysis of antibodies and related macromolecular immune complexes. The goal is to utilize a novel high-temperature superconducting...

This Project Grant award of $778,241 from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) will enable researchers at Colorado State University to develop and validate monoclonal antibodies and antibody-based biosensors targeting zebrafish proteins. The goal is to generate a publicly-available library of high-quality, cost-effective reagents to support increased rigor, reproducibility, and accessibility in zebrafish research, a powerful model system for biomedical studies. Key deliverables include: 1) recombinant antibodies against zebrafish proteins with defined sequences, including species variants to enhance experimental flexibility; and 2) genetically-encoded, fluorescently-tagged single-chain variable fragment (scFv) biosensors to track post-translational modifications of select zebrafish target proteins in living cells and organisms. An online resource will also be built to distribute these antibody products and provide protocols to the zebrafish research community. The award period runs from August 1, 2025 to July 31, 2029.

Generated 8/5/25, 3:12 AM